Currently out of the existing stock ratings of Yun Zhong, 61 are a BUY (81.33%), 14 are a HOLD (18.67%).

Yun Zhong

Work Performance Price Targets & Ratings Chart

Analyst Yun Zhong, currently employed at WEDBUSH, carries an average stock price target met ratio of 31.11% that have a potential upside of 24.85% achieved within 83 days. Previously, Yun Zhong worked at BTIG.

Yun Zhong’s has documented 138 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on ASND, Ascendis Pharma AS at 12-Feb-2026.

Wall Street Analyst Yun Zhong

Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 11/10/2025. The price target of $20 was fulfilled within 29 days with a profit of $12.95 (183.69%) receiving and performance score of 63.34.

Average potential price target upside

of $28.8 (73.06%) on MGTA (MAGENTA THERAPEUTICS).
of $25.69 (27.24%) on SRPT (SAREPTA THERAPEUTICS).
of $21.41 (12.27%) on ASND (ASCENDIS PHARMA AS).

AGTC Applied Genetic AVRO AVROBIO MGTA Magenta Therapeutics QURE Uniqure NV SIOX Sio Gene Therapies SRPT Sarepta Therapeutics TSHA Taysha Gene Therapies PASG Passage Bio AVXL Anavex Life Sciences Corp FOLD Amicus Therapeutics FRLN Freeline Therapeutics Holdings Plc GRPH Graphite Bio BLUE Bluebird bio FUTU Futu Holdings Ltd INSY INSYS Therapeutics RCOR Renovacor SELB Selecta Biosciences KROS Keros Therapeutics MLTX MoonLake Immunotherapeutics MRKR Marker Therapeutics PTGX Protagonist Therapeutics RCKT Rocket Pharmaceuticals VYGR Voyager Therapeutics ASND Ascendis Pharma AS RZLT Rezolute WVE Wave Life Sciences Ltd

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Joseph Pantginis (HC WAINWRIGHT)